Marc Pérez-Roig, David Fernández-Narro, Carlos Sáezcs.AI cs.LG
The dosing of intravenous fluids and vasopressors in sepsis is a sequential decision made under uncertainty and guided largely by clinical judgment, which makes it a natural target for reinforcement learning from historical care. Because a learned policy cannot be trialed on patients, its value must be estimated off-policy, and such estimates can be fragile and optimistic. This work advances the reliable evaluation of sepsis treatment policies by combining off-policy estimation, reliability diagnostics, and clinician-agreement analyses in a transparent validation framework. We modeled fluid and vasopressor dosing on a cohort of 36,872 septic ICU stays drawn from the MIMIC-IV critical-care database, as a discretized Markov decision process with 1,000 states and 25 actions, defined by a five-by-five grid of fluid and vasopressor levels and solved by policy iteration. The clinicians' behavior policy was estimated with a random forest, which mitigated the collapse of the Effective Sample Size (ESS 50.1 against 4.0 with smoothed counts) that otherwise destabilizes the importance-sampling estimate. The learned policy was evaluated with two estimators, weighted importance sampling (WIS) and fitted Q evaluation (FQE), with the ESS and clinician agreement as reliability checks. An empirical variable selection found that the composition of the state matters more than its size. Both estimators place the learned policy above the clinicians' return (WIS 50.8 and FQE 46.8 against 38.2, ESS 50.1), yet it departs only modestly from observed practice (total variation 0.18), favoring less intravenous fluid. These retrospective single-center off-policy results support the learned policy as a clinically plausible refinement of observed practice and motivate its further evaluation as a discordance-based clinical decision-support approach.
Verifying whether clinical care follows evidence-based protocols is a natural neuro-symbolic problem, yet the safety-critical setting defeats either paradigm alone. We present an expert-guided pipeline that constrains a large language model strictly to semantic normalization, mapping messy drug and microbiology strings onto a fixed clinical vocabulary, while a Sugeno fuzzy inference system reasons over the normalized events. The fuzzy layer encodes eight Surviving Sepsis Campaign bundle rules and replaces binary judgments with graded scores in [0,1]. Applied to 2,438 MIMIC-IV v3.1 sepsis episodes, it surfaces antibiotic timing as the most critical breakdown (mean 0.24, 13% within one hour), Hour-1 underperformance (mean 36.7%), a 51% elevated-lactate drop-off, and descriptive differences in ICU stay across compliance groups (3.8 versus 5.1 days).
Counterfactual inference approaches for sequential decision-making typically assume deterministic causal models, where all randomness stems from latent variables. However, Markov Decision Processes (MDPs) are inherently stochastic. We address this by formalising counterfactual policy optimisation under probabilistic nondeterministic causal models, which properly separates latent confounding from irreducible stochasticity, and here propose a first practical optimisation problem for identifying robust counterfactual policies under a sensitivity analysis framework. We validate our approach on a sepsis treatment simulator, where diabetes status acts as a hidden global confounder.
Joshua Pickard, Wei Qi, Na Li +4stat.ML cs.AI cs.LG eess.SY math.OC
Sepsis is a leading cause of mortality, yet optimal treatment policies remain contested. Existing reinforcement learning (RL) approaches learn fixed strategies for sepsis treatment, limiting adaptability to changing clinical objectives during inference. We propose EHRMPC, a framework that decouples learning patient dynamics from optimizing treatment by training a patient digital twin in the form of a generative electronic health record (EHR) model. The digital twin predicts clinical trajectories under interventions and enables model predictive control (MPC) to optimize treatments via inference-time planning over simulations. We evaluate EHR-MPC on a multicenter ICU sepsis cohort spanning 8 hospitals in the Mass General Brigham health system using both off-policy importance sampling and on-policy simulation-based evaluation. Relative to RL baselines, EHR-MPC achieves comparable off-policy performance and improved simulation performance. Unlike RL, this work frames sepsis treatment optimization as inference-time control over learned patient dynamics, establishing a general framework for decision making with generative clinical models.